92134-98-0 | disodium (2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl phosphate

Packsize	Purity	Availability	Price	Discounted Price
1mg	95%	in stock	$39.00	$28.00
5mg	95%	in stock	$44.00	$31.00
50mg	95%	in stock	$57.00	$40.00
100mg	95%	in stock	$84.00	$59.00
250mg	95%	in stock	$122.00	$86.00
1g	95%	in stock	$325.00	$228.00
5g	95%	in stock	$946.00	$662.00

Description

• Catalog Number: AD03069
• Chemical Name: disodium (2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl phosphate
• CAS Number: 92134-98-0
• Molecular Formula: C16H13N2Na2O6P
• Molecular Weight: 406.2375
• MDL Number: MFCD09029435
• SMILES: O=C1N(COP(=O)([O-])[O-])C(=O)NC1(c1ccccc1)c1ccccc1.[Na+].[Na+]

Computed Properties

• Complexity: 536
• Covalently-Bonded Unit Count: 3
• Heavy Atom Count: 27
• Hydrogen Bond Acceptor Count: 6
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 4

Literature

• Levetiracetam for busulfan-induced seizure prophylaxis in children undergoing hematopoietic stem cell transplantation.

  Pediatric blood & cancer 20121001

• Initial EEG predicts outcomes in a trial of levetiracetam vs. fosphenytoin for seizure prevention.

  Epilepsy & behavior : E&B 20120301

• Evaluation of intramuscular fosphenytoin vs intravenous phenytoin loading in the ED.

  The American journal of emergency medicine 20111101

• Subacute encephalopathy and seizures in alcoholics (SESA) presenting with non-convulsive status epilepticus.

  Seizure 20110701

• Video recording devices as a diagnostic aid.

  The Journal of emergency medicine 20110401

• Advisers recommend improved labeling for phenytoin, fosphenytoin.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20101215

• [Antiepileptic drugs in North America].

  Brain and nerve = Shinkei kenkyu no shinpo 20100501

• Possible acute thrombocytopenia post esomeprazole and hydantoin coadministration.

  Journal of pharmacy practice 20100401

• Persistent focal seizures after cat scratch encephalopathy.

  Pediatric neurology 20100301

• Sporadic hemiplegic migraine and epilepsy associated with CACNA1A gene mutation.

  Epilepsy & behavior : E&B 20100201

• Effect of an educational initiative on physicians' use of weight-based fosphenytoin loading doses in the emergency department.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100101

• Blood pressure changes after intravenous fosphenytoin and levetiracetam in patients with acute cerebral symptoms.

  Epilepsy research 20091201

• What is the relative value of the standard anticonvulsants: Phenytoin and fosphenytoin, phenobarbital, valproate, and levetiracetam?

  Epilepsia 20091201

• Minimum requirements for approval of a drug in status epilepticus.

  Epilepsia 20091201

• Evaluation of in vitro models for screening alkaline phosphatase-mediated bioconversion of phosphate ester prodrugs.

  Drug metabolism and disposition: the biological fate of chemicals 20090701

• Fosphenytoin.

  Expert opinion on drug metabolism & toxicology 20090601

• Case 3-2009: a 9-month-old boy with seizures.

  The New England journal of medicine 20090409

• FDA: Epilepsy drugs may carry skin risks for Asians.

  JAMA 20081224

• Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus.

  Epilepsy research 20081101

• Fatal errors with cerebyx.

  Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association 20081001

• Clinical trial: a dose-response study of fospropofol disodium for moderate sedation during colonoscopy.

  Alimentary pharmacology & therapeutics 20080401

• Rotavirus-induced seizures in childhood.

  Journal of child neurology 20071201

• Clinical pharmacology of parenteral use of antiepileptic drugs.

  Epilepsia 20070101

• Interpretation of serum phenytoin concentrations: who would have thought that preventing and treating seizures were this challenging?

  Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 20060901

• Fosphenytoin may cause hemodynamically unstable bradydysrhythmias.

  The Journal of emergency medicine 20060101

• Administer single-site 30-mL intramuscular injection?

  Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses 20051201

• Treatment delay and the risk of prolonged status epilepticus.

  Neurology 20051025

• Hyperphosphatemia due to fosphenytoin in a pediatric ESRD patient.

  Pediatric nephrology (Berlin, Germany) 20050801

• Impact of phenytoin therapy on the skin and skin disease.

  Expert opinion on drug safety 20041101

• Catheter occlusion from intravenous phenytoin.

  Annals of emergency medicine 20041001

• Nurse sued when child dies from error in interpreting drug dosage.

  Nursing law's Regan report 20041001

• Treatment of status epilepticus in children.

  Pediatric annals 20040601

• Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with seizures.

  Annals of emergency medicine 20040501

• Frontal lobe seizures and uveitis associated with acute human parvovirus B19 infection.

  Journal of child neurology 20040401

• Cost-effectiveness of oral phenytoin, intravenous phenytoin, and intravenous fosphenytoin in the emergency department.

  Annals of emergency medicine 20040301

• Fosphenytoin farewell?

  Annals of emergency medicine 20040301

• A comparison of phenytoin-loading techniques in the emergency department.

  Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 20040301

• Effects of fosphenytoin on nerve agent-induced status epilepticus.

  Drug and chemical toxicology 20040201

• A comparison of central brain (cerebrospinal and extracellular fluids) and peripheral blood kinetics of phenytoin after intravenous phenytoin and fosphenytoin.

  Seizure 20030901

• Enzyme-mediated precipitation of parent drugs from their phosphate prodrugs.

  International journal of pharmaceutics 20030811

• Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.

  British journal of clinical pharmacology 20030701

• Absorption rate limit considerations for oral phosphate prodrugs.

  Pharmaceutical research 20030601

• New management strategies in the treatment of status epilepticus.

  Mayo Clinic proceedings 20030401

• Intravenous fosphenytoin in acute mania.

  The Journal of clinical psychiatry 20030401

• Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.

  Clinical pharmacokinetics 20030101

• Phenytoin pharmacokinetics and clinical effects in African children following fosphenytoin and chloramphenicol coadministration.

  British journal of clinical pharmacology 20021201

• Randomized evaluation of adverse events and length-of-stay with routine emergency department use of phenytoin or fosphenytoin.

  Neurological research 20021201

• New antiepileptic drug therapies.

  Neurologic clinics 20021101

• Hypocalcemia-like electrocardiographic changes after administration of intravenous fosphenytoin.

  Mayo Clinic proceedings 20020601

• Pharmacology advances in the neuroscience intensive care unit.

  Critical care nursing clinics of North America 20020301

• Subtherapeutic free phenytoin levels following fosphenytoin therapy in status epilepticus.

  Neurology 20020108

• Pharmacokinetics of phenytoin following intravenous and intramuscular administration of fosphenytoin and phenytoin sodium in the rabbit.

  European journal of drug metabolism and pharmacokinetics 20020101

• Inappropriate fosphenytoin use in the ED.

  The American journal of emergency medicine 20010701

• Fosphenytoin: an intravenous option for the management of acute trigeminal neuralgia crisis.

  Journal of pain and symptom management 20010601

• Prodrug metabolites: implications for therapeutic drug monitoring.

  Clinical chemistry 20010501

• Glucuronidation of prodrug reactive site: isolation and characterization of oxymethylglucuronide metabolite of fosphenytoin.

  Clinical chemistry 20010501

• Fosphenytoin in infants of extremely low birth weight.

  Pediatric neurology 20010301

• Fosphenytoin: pharmacokinetics and tolerance of intramuscular loading doses.

  Epilepsia 20010201

• Cardiac arrest after fast intravenous infusion of phenytoin mistaken for fosphenytoin.

  Epilepsia 20010201

• Rapid in vitro conversion of fosphenytoin into phenytoin in sera of patients with liver disease: role of alkaline phosphatase.

  Journal of clinical laboratory analysis 20010101

• Fosphenytoin.

  Dimensions of critical care nursing : DCCN 20010101

• Pediatric use of intravenous and intramuscular phenytoin: lessons learned.

  Journal of child neurology 19981001

• Pharmacology and pharmacokinetics of fosphenytoin.

  Neurology 19960601

• Venous irritation related to intravenous administration of phenytoin versus fosphenytoin.

  Pharmacotherapy 19940101

• Pharmacology of ACC-9653 (phenytoin prodrug).

  Epilepsia 19890101